kai-9531
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Jul 14, 2025 (NCT07044401)
Timeline
Indications
Studied for
Mechanism of action
GIPR agonist
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07284979 | Phase 3 | Dec 31, 2025 | Kailera |
| NCT07284875 | Phase 3 | Dec 31, 2025 | Kailera |
| NCT07284901 | Phase 3 | Dec 31, 2025 | Kailera |
| NCT07044401 | Phase 1 | Jul 14, 2025 | Kailera |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kailera | For profit | 4 | 4 | 2 | 2025 |
1 organizations
Page 1 / 1